285 related articles for article (PubMed ID: 18678351)
1. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.
Wang F; Wang Z; Wu J; Qu W; Yao W; Zhao J; Liu Z
Nucl Med Biol; 2008 Aug; 35(6):665-71. PubMed ID: 18678351
[TBL] [Abstract][Full Text] [Related]
2. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Wang F; Wang Z; Yao W; Xie H; Xu J; Tian L
J Nucl Med; 2007 Sep; 48(9):1442-8. PubMed ID: 17704242
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide.
Van Den Bossche B; D'haeninck E; De Vos F; Dierckx RA; Van Belle S; Bracke M; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1022-30. PubMed ID: 15029461
[TBL] [Abstract][Full Text] [Related]
4. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.
Herlin G; Kölbeck KG; Menzel PL; Svensson L; Aspelin P; Capitanio A; Axelsson R
Acta Radiol; 2009 Oct; 50(8):902-8. PubMed ID: 19707908
[TBL] [Abstract][Full Text] [Related]
7. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
9. [Expression of somatostatin receptor reporter gene and its correlation with targeted imaging in vivo for detection of pancreas carcinoma].
Wang ZZ; Qu W; Wang F; Li Y; Wang SK; Wang JQ
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):663-6. PubMed ID: 16438887
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.
Czepczyński R; Parisella MG; Kosowicz J; Mikołajczak R; Ziemnicka K; Gryczyńska M; Sowiński J; Signore A
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1635-45. PubMed ID: 17530247
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.
Li Y; Si JM; Zhang J; Du J; Wang F; Jia B
World J Gastroenterol; 2005 Jul; 11(25):3953-7. PubMed ID: 15991301
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
13. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
[TBL] [Abstract][Full Text] [Related]
14. Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer.
Chen J; Wu H; Zhou J; Hu J
Chin Med J (Engl); 2003 Apr; 116(4):620-4. PubMed ID: 12875735
[TBL] [Abstract][Full Text] [Related]
15. Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.
Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
J Neurooncol; 2013 Jul; 113(3):519-26. PubMed ID: 23657621
[TBL] [Abstract][Full Text] [Related]
16. Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.
Van Den Bossche B; Van Belle S; De Winter F; Signore A; Van de Wiele C
J Nucl Med; 2006 Jan; 47(1):6-13. PubMed ID: 16391181
[TBL] [Abstract][Full Text] [Related]
17. Distribution and functional significance of somatostatin receptors in malignant melanoma.
Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
[TBL] [Abstract][Full Text] [Related]
18. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.
Burggasser G; Hurtl I; Hauff W; Lukas J; Greifeneder M; Heydari B; Thaler A; Wedrich A; Virgolini I
J Nucl Med; 2003 Oct; 44(10):1547-55. PubMed ID: 14530465
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study.
Decristoforo C; Maina T; Nock B; Gabriel M; Cordopatis P; Moncayo R
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1211-9. PubMed ID: 12845487
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of combined diagnostic CT and (99m)Tc-octreotide somatostatin receptor SPECT/CT imaging on pulmonary nodule characterization in patients.
Wang L; Yin X; Wang F; Gu J; Lu L; Wu Q; Shen B; Li XF
Cancer Biother Radiopharm; 2013 Dec; 28(10):731-6. PubMed ID: 24094076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
